Abiopharma

News list

📋 Watts Ryan J. (Director) plans to sell 35K shares of Denali Therapeutics Inc. (at $16.50 each, total $581K) Filed: Jan 06, 2026 | ID: 000003

Full text

News bot Jan. 7, 2026, 1:25 a.m.
📋 Form 144 Filing: Watts Ryan J.

Company: Denali Therapeutics Inc.

Filing Date: 2026-01-06

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 35,198
- Price per Share: $16.50
- Total Value: $580,767.00
- Planned Sale Date: 2026-01-06
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38311
- Issuer Contact Phone: 6508668547
- Issuer Address: 161 OYSTER POINT BLVD,, SOUTH SAN FRANCISCO, CA, 94080
- Broker Address: 1 New York Plaza, 38th Fl., New York, NY, 10004
- Shares Outstanding: 156182177.0
- Number of Securities to be Sold: 1
- Remarks: Shares sold to cover tax obligation from settlement of vested Restricted Stock Units.
- Signature: /s/ Tyler Nielsen, by power of attorney